loading

Foghorn Therapeutics Inc Azioni (FHTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
12.46%
5.05
5.769 17.48 5.599 5.309
Operating Expenses
6.46%
33.24
31.23 34.56 37.65 38.63
Benefits Costs and Expenses
7.81%
30.07
27.89 31.09 34.14 35.24
Costs And Expenses
7.81%
30.07
27.89 31.09 34.14 35.24
Operating Income/Loss
10.75%
-28.19
-25.46 -17.08 -32.05 -33.32
Nonoperating Income/Loss
4.79%
3.178
3.338 3.474 3.505 3.389
Income/Loss From Continuing Operations Before Tax
13.09%
-25.02
-22.12 -13.61 -28.55 -29.93
Income Tax Expense/Benefit
100.00%
-
1.986 0.738 0.942 0.56
Income/Loss From Continuing Operations After Tax
3.77%
-25.02
-24.11 -14.35 -29.49 -30.49
Net Income/Loss
3.77%
-25.02
-24.11 -14.35 -29.49 -30.49
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
49,138%
42.43
0.0862 42.03 41.83 41.81
Diluted Average Shares
49,138%
42.43
0.0862 42.03 41.83 41.81
Basic Earnings Per Share
3.51%
-0.59
-0.57 -0.34 -0.70 -0.73
Diluted Earnings Per Share
3.51%
-0.59
-0.57 -0.34 -0.70 -0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.94
price down icon 0.70%
$38.66
price up icon 7.63%
$372.13
price up icon 1.15%
$24.03
price up icon 8.06%
biotechnology ONC
$219.76
price up icon 0.47%
$114.86
price down icon 2.03%
Capitalizzazione:     |  Volume (24 ore):